Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry-Plasma peptidomes from nasopharyngeal cancer patients for example

Joseph Tung Chieh Chang, Li Chiu Chen, Shang Yi Wei, Yin Ju Chen, Hung Ming Wang, Chun Ta Liao, I. How Chen, Ann Joy Cheng

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Objectives: There is no plasma marker for detecting nasopharyngeal cancer (NPC). We developed a bead-based affinity fractionated proteomic method to search potential plasma markers for NPC. Design and methods: Affinity purification of heparinized plasma with Cu-chelated beads and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis were used to screen potential NPC markers. We compiled MS protein profiles for 47 patients with NPC and compared them to profiles from 28 healthy controls. The spectra were statistically analyzed using flexAnalysis™ and ClinProt™ bioinformatics software. Diagnostic efficacy was evaluated by determination of the assay sensitivity and specificity of each marker. Results: Twelve mass fingerprint markers differing between cancer and control spectra were found. The sensitivities of these NPC markers are various ranging from 36% to 83%, and the specificities were all over 90%. Combine use of these markers significantly increases diagnostic efficacy. In which, the combined markers (2020 Da and 4635 Da) possess best discriminator with high sensitivity (94%) and specificity (93%). We further identify a C3 fragment, C3f, that may serve as a biomarker for NPC. Conclusion: The combined use of mass fingerprint markers in plasma proteome will enhance diagnostic efficacy for NPC. This method can be applied to search for novel plasma markers for cancers.

Original languageEnglish
Pages (from-to)1144-1151
Number of pages8
JournalClinical Biochemistry
Volume39
Issue number12
DOIs
Publication statusPublished - Dec 2006
Externally publishedYes

Fingerprint

Nasopharyngeal Neoplasms
Dermatoglyphics
Mass spectrometry
Mass Spectrometry
Plasmas
Discriminators
Biomarkers
Proteome
Bioinformatics
Sensitivity and Specificity
Ionization
Purification
Assays
Desorption
Computational Biology
Proteomics
Neoplasms
Lasers
Software
Proteins

Keywords

  • Complement 3
  • MALDI-TOF
  • Nasopharyngeal cancer
  • Plasma proteome
  • Tumor marker

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry-Plasma peptidomes from nasopharyngeal cancer patients for example. / Chang, Joseph Tung Chieh; Chen, Li Chiu; Wei, Shang Yi; Chen, Yin Ju; Wang, Hung Ming; Liao, Chun Ta; Chen, I. How; Cheng, Ann Joy.

In: Clinical Biochemistry, Vol. 39, No. 12, 12.2006, p. 1144-1151.

Research output: Contribution to journalArticle

Chang, Joseph Tung Chieh ; Chen, Li Chiu ; Wei, Shang Yi ; Chen, Yin Ju ; Wang, Hung Ming ; Liao, Chun Ta ; Chen, I. How ; Cheng, Ann Joy. / Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry-Plasma peptidomes from nasopharyngeal cancer patients for example. In: Clinical Biochemistry. 2006 ; Vol. 39, No. 12. pp. 1144-1151.
@article{abce4d0f40224b208809b31e9b20de74,
title = "Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry-Plasma peptidomes from nasopharyngeal cancer patients for example",
abstract = "Objectives: There is no plasma marker for detecting nasopharyngeal cancer (NPC). We developed a bead-based affinity fractionated proteomic method to search potential plasma markers for NPC. Design and methods: Affinity purification of heparinized plasma with Cu-chelated beads and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis were used to screen potential NPC markers. We compiled MS protein profiles for 47 patients with NPC and compared them to profiles from 28 healthy controls. The spectra were statistically analyzed using flexAnalysis™ and ClinProt™ bioinformatics software. Diagnostic efficacy was evaluated by determination of the assay sensitivity and specificity of each marker. Results: Twelve mass fingerprint markers differing between cancer and control spectra were found. The sensitivities of these NPC markers are various ranging from 36{\%} to 83{\%}, and the specificities were all over 90{\%}. Combine use of these markers significantly increases diagnostic efficacy. In which, the combined markers (2020 Da and 4635 Da) possess best discriminator with high sensitivity (94{\%}) and specificity (93{\%}). We further identify a C3 fragment, C3f, that may serve as a biomarker for NPC. Conclusion: The combined use of mass fingerprint markers in plasma proteome will enhance diagnostic efficacy for NPC. This method can be applied to search for novel plasma markers for cancers.",
keywords = "Complement 3, MALDI-TOF, Nasopharyngeal cancer, Plasma proteome, Tumor marker",
author = "Chang, {Joseph Tung Chieh} and Chen, {Li Chiu} and Wei, {Shang Yi} and Chen, {Yin Ju} and Wang, {Hung Ming} and Liao, {Chun Ta} and Chen, {I. How} and Cheng, {Ann Joy}",
year = "2006",
month = "12",
doi = "10.1016/j.clinbiochem.2006.08.010",
language = "English",
volume = "39",
pages = "1144--1151",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry-Plasma peptidomes from nasopharyngeal cancer patients for example

AU - Chang, Joseph Tung Chieh

AU - Chen, Li Chiu

AU - Wei, Shang Yi

AU - Chen, Yin Ju

AU - Wang, Hung Ming

AU - Liao, Chun Ta

AU - Chen, I. How

AU - Cheng, Ann Joy

PY - 2006/12

Y1 - 2006/12

N2 - Objectives: There is no plasma marker for detecting nasopharyngeal cancer (NPC). We developed a bead-based affinity fractionated proteomic method to search potential plasma markers for NPC. Design and methods: Affinity purification of heparinized plasma with Cu-chelated beads and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis were used to screen potential NPC markers. We compiled MS protein profiles for 47 patients with NPC and compared them to profiles from 28 healthy controls. The spectra were statistically analyzed using flexAnalysis™ and ClinProt™ bioinformatics software. Diagnostic efficacy was evaluated by determination of the assay sensitivity and specificity of each marker. Results: Twelve mass fingerprint markers differing between cancer and control spectra were found. The sensitivities of these NPC markers are various ranging from 36% to 83%, and the specificities were all over 90%. Combine use of these markers significantly increases diagnostic efficacy. In which, the combined markers (2020 Da and 4635 Da) possess best discriminator with high sensitivity (94%) and specificity (93%). We further identify a C3 fragment, C3f, that may serve as a biomarker for NPC. Conclusion: The combined use of mass fingerprint markers in plasma proteome will enhance diagnostic efficacy for NPC. This method can be applied to search for novel plasma markers for cancers.

AB - Objectives: There is no plasma marker for detecting nasopharyngeal cancer (NPC). We developed a bead-based affinity fractionated proteomic method to search potential plasma markers for NPC. Design and methods: Affinity purification of heparinized plasma with Cu-chelated beads and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis were used to screen potential NPC markers. We compiled MS protein profiles for 47 patients with NPC and compared them to profiles from 28 healthy controls. The spectra were statistically analyzed using flexAnalysis™ and ClinProt™ bioinformatics software. Diagnostic efficacy was evaluated by determination of the assay sensitivity and specificity of each marker. Results: Twelve mass fingerprint markers differing between cancer and control spectra were found. The sensitivities of these NPC markers are various ranging from 36% to 83%, and the specificities were all over 90%. Combine use of these markers significantly increases diagnostic efficacy. In which, the combined markers (2020 Da and 4635 Da) possess best discriminator with high sensitivity (94%) and specificity (93%). We further identify a C3 fragment, C3f, that may serve as a biomarker for NPC. Conclusion: The combined use of mass fingerprint markers in plasma proteome will enhance diagnostic efficacy for NPC. This method can be applied to search for novel plasma markers for cancers.

KW - Complement 3

KW - MALDI-TOF

KW - Nasopharyngeal cancer

KW - Plasma proteome

KW - Tumor marker

UR - http://www.scopus.com/inward/record.url?scp=33751520049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751520049&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2006.08.010

DO - 10.1016/j.clinbiochem.2006.08.010

M3 - Article

VL - 39

SP - 1144

EP - 1151

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 12

ER -